FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800153422> ?p ?o ?g. }

• W2800153422 endingPage "e0195536" @default.
• W2800153422 startingPage "e0195536" @default.
• W2800153422 abstract "In critically sick adults, sustained low efficiency dialysis [SLED] appears to be better tolerated hemodynamically and outcomes seem to be comparable to CRRT. However, there is paucity of data in critically sick children. In children, two recent studies from Taiwan (n = 11) and India (n = 68) showed benefits of SLED in critically sick children.The objective of the study was to look at the feasibility and tolerability of sustained low efficiency daily dialysis-filtration [SLEDD-f] in critically sick pediatric patients.Design: Retrospective study Inclusion criteria: All pediatric patients who had undergone heparin free SLEDD-f from January 2012 to October 2017. Measurements: Data collected included demographic details, vital signs, PRISM III at admission, ventilator parameters (where applicable), number of inotropes, blood gas and electrolytes before, during, and on conclusion of SLED therapy. Technical information was gathered regarding SLEDD-f prescription and complications.Between 2012-2017, a total of 242 sessions of SLEDD-f were performed on 70 patients, out of which 40 children survived. The median age of patients in years was 12 (range 0.8-17 years), and the median weight was 39 kg (range 8.5-66 kg). The mean PRISM score at admission was 8.77±7.22. SLEDD-f sessions were well tolerated, with marked improvement in fluid status and acidosis. Premature terminations had to be done in 23 (9.5%) of the sessions. There were 21 sessions (8.6%) terminated due to hypotension and 2 sessions (0.8%) terminated due to circuit clotting. Post- SLEDD-f hypocalcemia occurred in 15 sessions (6.2%), post- SLEDD-f hypophosphatemia occurred in 1 session (0.4%), and post- SLEDD-f hypokalemia occurred in 17 sessions (7.0%).This study is the largest compiled data on pediatric SLEDD-f use in critically ill patients. Our study confirms the feasibility of heparin free SLEDD-f in a larger pediatric population, and even in children weighing <20 kg on inotropic support." @default.
• W2800153422 created "2018-05-17" @default.
• W2800153422 creator A5006830135 @default.
• W2800153422 creator A5012029946 @default.
• W2800153422 creator A5025508412 @default.
• W2800153422 creator A5031816282 @default.
• W2800153422 creator A5039331448 @default.
• W2800153422 creator A5046102036 @default.
• W2800153422 creator A5055214463 @default.
• W2800153422 creator A5082043311 @default.
• W2800153422 creator A5083689179 @default.
• W2800153422 creator A5088218732 @default.
• W2800153422 date "2018-04-26" @default.
• W2800153422 modified "2023-10-18" @default.
• W2800153422 title "Heparin free dialysis in critically sick children using sustained low efficiency dialysis (SLEDD-f): A new hybrid therapy for dialysis in developing world" @default.
• W2800153422 cites W1605691392 @default.
• W2800153422 cites W1885692492 @default.
• W2800153422 cites W1968121673 @default.
• W2800153422 cites W1977108608 @default.
• W2800153422 cites W1981671731 @default.
• W2800153422 cites W1983494099 @default.
• W2800153422 cites W1988718249 @default.
• W2800153422 cites W1997278766 @default.
• W2800153422 cites W2011267426 @default.
• W2800153422 cites W2024666483 @default.
• W2800153422 cites W2041840881 @default.
• W2800153422 cites W2054789168 @default.
• W2800153422 cites W2060357576 @default.
• W2800153422 cites W2073866989 @default.
• W2800153422 cites W2076590961 @default.
• W2800153422 cites W2081835715 @default.
• W2800153422 cites W2085202645 @default.
• W2800153422 cites W2085995657 @default.
• W2800153422 cites W2086784986 @default.
• W2800153422 cites W2094581349 @default.
• W2800153422 cites W2114300057 @default.
• W2800153422 cites W2137482945 @default.
• W2800153422 cites W2140381573 @default.
• W2800153422 cites W2145174113 @default.
• W2800153422 cites W2148973700 @default.
• W2800153422 cites W2171696781 @default.
• W2800153422 cites W2326683632 @default.
• W2800153422 cites W2580128646 @default.
• W2800153422 cites W2582602949 @default.
• W2800153422 cites W2617560919 @default.
• W2800153422 cites W2737692422 @default.
• W2800153422 cites W2761060227 @default.
• W2800153422 cites W38018626 @default.
• W2800153422 cites W4252306088 @default.
• W2800153422 doi "https://doi.org/10.1371/journal.pone.0195536" @default.
• W2800153422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5919674" @default.
• W2800153422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29698409" @default.
• W2800153422 hasPublicationYear "2018" @default.
• W2800153422 type Work @default.
• W2800153422 sameAs 2800153422 @default.
• W2800153422 citedByCount "15" @default.
• W2800153422 countsByYear W28001534222019 @default.
• W2800153422 countsByYear W28001534222020 @default.
• W2800153422 countsByYear W28001534222021 @default.
• W2800153422 countsByYear W28001534222022 @default.
• W2800153422 countsByYear W28001534222023 @default.
• W2800153422 crossrefType "journal-article" @default.
• W2800153422 hasAuthorship W2800153422A5006830135 @default.
• W2800153422 hasAuthorship W2800153422A5012029946 @default.
• W2800153422 hasAuthorship W2800153422A5025508412 @default.
• W2800153422 hasAuthorship W2800153422A5031816282 @default.
• W2800153422 hasAuthorship W2800153422A5039331448 @default.
• W2800153422 hasAuthorship W2800153422A5046102036 @default.
• W2800153422 hasAuthorship W2800153422A5055214463 @default.
• W2800153422 hasAuthorship W2800153422A5082043311 @default.
• W2800153422 hasAuthorship W2800153422A5083689179 @default.
• W2800153422 hasAuthorship W2800153422A5088218732 @default.
• W2800153422 hasBestOaLocation W28001534221 @default.
• W2800153422 hasConcept C126322002 @default.
• W2800153422 hasConcept C141071460 @default.
• W2800153422 hasConcept C177713679 @default.
• W2800153422 hasConcept C187212893 @default.
• W2800153422 hasConcept C197934379 @default.
• W2800153422 hasConcept C2426938 @default.
• W2800153422 hasConcept C2777557582 @default.
• W2800153422 hasConcept C2778063415 @default.
• W2800153422 hasConcept C2778375690 @default.
• W2800153422 hasConcept C2779978075 @default.
• W2800153422 hasConcept C2991859549 @default.
• W2800153422 hasConcept C71924100 @default.
• W2800153422 hasConcept C98274493 @default.
• W2800153422 hasConceptScore W2800153422C126322002 @default.
• W2800153422 hasConceptScore W2800153422C141071460 @default.
• W2800153422 hasConceptScore W2800153422C177713679 @default.
• W2800153422 hasConceptScore W2800153422C187212893 @default.
• W2800153422 hasConceptScore W2800153422C197934379 @default.
• W2800153422 hasConceptScore W2800153422C2426938 @default.
• W2800153422 hasConceptScore W2800153422C2777557582 @default.
• W2800153422 hasConceptScore W2800153422C2778063415 @default.
• W2800153422 hasConceptScore W2800153422C2778375690 @default.
• W2800153422 hasConceptScore W2800153422C2779978075 @default.
• W2800153422 hasConceptScore W2800153422C2991859549 @default.
• W2800153422 hasConceptScore W2800153422C71924100 @default.

• next